| Trial ID: | L6950 |
| Source ID: | NCT01951183
|
| Associated Drug: |
Placebo
|
| Title: |
A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Placebo|DRUG: RO6811135
|
| Outcome Measures: |
Primary: Change from baseline in HbA1c, from baseline to Week 12 | Secondary: Change from baseline in fasting plasma glucose (FPG), from baseline to Week 12|Pharmacokinetics: Area under the concentration-time curve (AUC), 12 weeks|Safety: Incidence of adverse events, 19 weeks
|
| Sponsor/Collaborators: |
Sponsor: Hoffmann-La Roche
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-12
|
| Completion Date: |
2013-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-11-02
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01951183
|
